Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EAN 2017 | Pioglitazone for the treatment of Alzheimer’s disease

Daniela Galimberti • 24 Jun 2017
EAN 2017
Alzheimer’s Disease Dementia Pioglitazone

Daniela Galimberti, PhD from the University of Milan, Milan, Italy discusses a study on pioglitazone for the treatment of Alzheimer’s disease at the 2017 Congress of the European Academy of Neurology (EAN) in Amsterdam, the Netherlands. The drug acts on a receptor involved in inflammatory mechanisms and the rationale is to interfere with inflammation in Alzheimer’s disease.

More from Daniela Galimberti

Risk factors for developing dementia
1:15
Risk factors for developing dementia
Daniela Galimberti • 24 Jun 2017
Genetic counseling for dementia
1:27
Genetic counseling for dementia
Daniela Galimberti • 25 Jun 2017

Related Videos

A multimodal model to detect and stage Alzheimer's disease using MRI, acoustic signals, and genetics
10:28
A multimodal model to detect and stage Alzheimer's disease using MRI, acoustic signals, and genetics
Muhammad Umar Khan • 28 Aug 2026
Neuroprotective effects of aortic valve replacement: a propensity score-matched cohort study
3:25
Neuroprotective effects of aortic valve replacement: a propensity score-matched cohort study
Vikash Jaiswal • 26 Aug 2026
Neflamapimod receives ILAP designation in the UK for dementia with Lewy bodies
2:44
Neflamapimod receives ILAP designation in the UK for dementia with Lewy bodies
Jacqui Cannon • 5 Aug 2026
The Lewy Body Society's mission and impact
2:38
The Lewy Body Society's mission and impact
Jacqui Cannon • 5 Aug 2026

Choose your cookie settings

VJDementia uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJDementia is intended for healthcare professionals